BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26646999)

  • 1. Follicular Thyroid Adenoma Showing Avid Uptake on 68Ga PSMA-HBED-CC PET/CT.
    Kanthan GL; Drummond J; Schembri GP; Izard MA; Hsiao E
    Clin Nucl Med; 2016 Apr; 41(4):331-2. PubMed ID: 26646999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular Lymphoma Showing Avid Uptake on 68Ga PSMA-HBED-CC PET/CT.
    Kanthan GL; Coyle L; Kneebone A; Schembri GP; Hsiao E
    Clin Nucl Med; 2016 Jun; 41(6):500-1. PubMed ID: 26914565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSMA Expression in Tumor Neovasculature Endothelial Cells of Follicular Thyroid Adenoma as Identified by Molecular Imaging Using 68Ga-PSMA Ligand PET/CT.
    Derlin T; Kreipe HH; Schumacher U; Soudah B
    Clin Nucl Med; 2017 Mar; 42(3):e173-e174. PubMed ID: 27997422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schwannoma Showing Avid Uptake on 68Ga-PSMA-HBED-CC PET/CT.
    Kanthan GL; Izard MA; Emmett L; Hsiao E; Schembri GP
    Clin Nucl Med; 2016 Sep; 41(9):703-4. PubMed ID: 27405039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoid Tumor Showing Intense Uptake on 68Ga PSMA-HBED-CC PET/CT.
    Kanthan GL; Hsiao E; Kneebone A; Eade T; Schembri GP
    Clin Nucl Med; 2016 Jun; 41(6):508-9. PubMed ID: 26909712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 68Ga-PSMA Uptake in Hepatocellular Carcinoma.
    Taneja S; Taneja R; Kashyap V; Jha A; Jena A
    Clin Nucl Med; 2017 Jan; 42(1):e69-e70. PubMed ID: 27607177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.
    Rauscher I; Maurer T; Beer AJ; Graner FP; Haller B; Weirich G; Doherty A; Gschwend JE; Schwaiger M; Eiber M
    J Nucl Med; 2016 Nov; 57(11):1713-1719. PubMed ID: 27261524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic poorly differentiated prostatic carcinoma with neuroendocrine differentiation: negative on 68Ga-PSMA PET/CT.
    Chakraborty PS; Tripathi M; Agarwal KK; Kumar R; Vijay MK; Bal C
    Clin Nucl Med; 2015 Feb; 40(2):e163-6. PubMed ID: 25275415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT.
    Lütje S; Gomez B; Cohnen J; Umutlu L; Gotthardt M; Poeppel TD; Bockisch A; Rosenbaum-Krumme S
    Clin Nucl Med; 2017 Jan; 42(1):20-25. PubMed ID: 27846003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic Prostate Carcinoma Presenting as a Superscan on 68Ga-PSMA PET/CT.
    Lawal I; Vorster M; Boshomane T; Ololade K; Ebenhan T; Sathekge M
    Clin Nucl Med; 2015 Sep; 40(9):755-6. PubMed ID: 26053729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.
    Afshar-Oromieh A; Avtzi E; Giesel FL; Holland-Letz T; Linhart HG; Eder M; Eisenhut M; Boxler S; Hadaschik BA; Kratochwil C; Weichert W; Kopka K; Debus J; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):197-209. PubMed ID: 25411132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer.
    Aydin F; Akçal A; Ünal B; Sezgin Göksu S; Güngör F
    Clin Nucl Med; 2017 May; 42(5):358-360. PubMed ID: 28240656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-PSMA-HBED-CC PET/CT.
    Verma P; Malhotra G; Agrawal R; Sonavane S; Meshram V; Asopa RV
    Clin Nucl Med; 2018 Aug; 43(8):e265-e268. PubMed ID: 29894335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subacute Cortical Infarct Showing Uptake on 68Ga-PSMA PET/CT.
    Chan M; Hsiao E
    Clin Nucl Med; 2017 Feb; 42(2):110-111. PubMed ID: 27997426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.
    Dietlein M; Kobe C; Kuhnert G; Stockter S; Fischer T; Schomäcker K; Schmidt M; Dietlein F; Zlatopolskiy BD; Krapf P; Richarz R; Neubauer S; Drzezga A; Neumaier B
    Mol Imaging Biol; 2015 Aug; 17(4):575-84. PubMed ID: 26013479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma.
    Sahlmann CO; Meller B; Bouter C; Ritter CO; Ströbel P; Lotz J; Trojan L; Meller J; Hijazi S
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):898-905. PubMed ID: 26563122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal Carcinoma on 68Ga-PSMA PET/CT.
    Huang YT; Fong W; Thomas P
    Clin Nucl Med; 2016 Mar; 41(3):e167-8. PubMed ID: 26571447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental Detection of Thyroid Metastases From Renal Cell Carcinoma Using 68Ga-PSMA PET/CT to Assess Prostate Cancer Recurrence.
    Zacho HD; Nielsen JB; Dettmann K; Haberkorn U; Petersen LJ
    Clin Nucl Med; 2017 Mar; 42(3):221-222. PubMed ID: 28033223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serous Cystadenoma of the Pancreas Showing Uptake on 68Ga PSMA PET/CT.
    Chan M; Schembri GP; Hsiao E
    Clin Nucl Med; 2017 Jan; 42(1):56-57. PubMed ID: 27764044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.